| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/14/2010 | WO2010003992A1 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 01/14/2010 | WO2010003805A1 Novel therapeutic use of a pharmaceutical composition for the reduction of the number of aberrant crypt foci and for the prevention of colon cancer |
| 01/14/2010 | WO2010003700A1 9-alpha estratriene derivatives as er-beta selective ligands for the prevention and treatment of intestinal cancer |
| 01/14/2010 | WO2010003668A2 Treatment of solid tumors with tissue inhibitors of metalloproteinases (timps) |
| 01/14/2010 | WO2010003376A1 Methods for treatment and/or prevention of cancer with andrographolide (and) and use thereof |
| 01/14/2010 | WO2010003369A1 Cyclin-dependent kinases inhibitor of baicalin organic amine derivatives, synthesis and use thereof |
| 01/14/2010 | WO2010003313A1 Icotinib hydrochloride, synthesis, crystallographic form, medical combination, and uses thereof |
| 01/14/2010 | WO2010003308A1 The use of nitric oxide and signal transduction system thereof in preparing medicaments for targeted therapy of malignant tumors |
| 01/14/2010 | WO2010003279A2 A cryosurgery anticancer antigen preparation and its preparation method |
| 01/14/2010 | WO2010003240A1 Gmcsf and truncated ccl2 conjugates and methods and uses thereof |
| 01/14/2010 | WO2010003232A1 Treating cancer using atractyloside |
| 01/14/2010 | WO2010003231A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 01/14/2010 | WO2010003193A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 01/14/2010 | WO2009143371A3 COMPOSITIONS COMPRISING mTOR SIRNA AND METHODS OF USE THEREOF |
| 01/14/2010 | WO2009143167A3 Dual delivery system for heterologous antigens |
| 01/14/2010 | WO2009142754A4 Dendritic conjugates and methods of use |
| 01/14/2010 | WO2009141050A3 Linear self-eliminating oligomers |
| 01/14/2010 | WO2009140754A8 An anti-cancer cytotoxic monoclonal antibody |
| 01/14/2010 | WO2009138396A3 Conjugates for the treatment of mesothelioma |
| 01/14/2010 | WO2009128917A3 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| 01/14/2010 | WO2009126551A3 Bis-aromatic anticancer agents |
| 01/14/2010 | WO2009126335A3 Ant2 inhibitor compounds and methods of use thereof |
| 01/14/2010 | WO2009124103A3 Combination therapies comprising par1 antagonists with par4 antagonists |
| 01/14/2010 | WO2009108856A3 Microrna signatures associated with human chronic lymphocytic leukemia (ccl) and uses thereof |
| 01/14/2010 | WO2009104100A3 Antibody combinations, and methods of making and using same |
| 01/14/2010 | WO2009103969A8 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions |
| 01/14/2010 | WO2009099650A4 Treatment of bladder diseases with a tlr7 activator |
| 01/14/2010 | WO2009099465A3 Methods of using mir-199a as a marker and sequences of mir-199a as a therapeutic for cancer |
| 01/14/2010 | WO2009098464A3 Use of g-rich oligonucleotides for treating neoplastic diseases |
| 01/14/2010 | WO2009073139A3 Combined treatment with an egfr kinase inhibitor and an inhibitor of c-kit |
| 01/14/2010 | WO2009052090A3 Silicate containing compositions and methods of treatment |
| 01/14/2010 | WO2008133709A3 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 01/14/2010 | WO2008083312A3 Chemical linkers and cleavable substrates and conjugates thereof |
| 01/14/2010 | US20100010207 Rna interference mediating small rna molecules |
| 01/14/2010 | US20100010193 Immunogenic complexes and methods relating thereto |
| 01/14/2010 | US20100010099 Medium and device for proliferation of stem cells and treatment of cancer-related stem cell with resveratrol |
| 01/14/2010 | US20100010094 Novel nitrophenyl mustard and nitrophenylaziridine alcohols and their corresponding phosphates and their use as targeted cytotoxic agents |
| 01/14/2010 | US20100010084 High penetration prodrug compositions of retinoids and retinoid-related compounds |
| 01/14/2010 | US20100010083 Pharmaceutical composition for oral administration |
| 01/14/2010 | US20100010081 Anti-tumor effect of dimeric phthalide compound |
| 01/14/2010 | US20100010078 Methods of treating androgen dependent prostate cancer by administering an active pharmaceutical ingredient being fisetin, 3,3',4',7-tetrahydroxyflavone or a derivative thereof, in an oral, transdermal or topical dosage form |
| 01/14/2010 | US20100010072 Microrna biomarkers for human breast and lung cancer |
| 01/14/2010 | US20100010071 Compositions and use of EPAS1 inhibitors |
| 01/14/2010 | US20100010064 Cancer treatment by combined inhibition of proteasome and telomerase activities |
| 01/14/2010 | US20100010059 Anticancer oral formulation |
| 01/14/2010 | US20100010057 Thiazole derivatives as inhibitors of p13 kinase |
| 01/14/2010 | US20100010053 3-[7-(5-{3-Chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-yl]propanoic acid; multiple sclerosis, autoimmune diseases, chronic inflammatory disorders, asthma, inflammatory neuropathies, arthritis, transplantation, Crohn's disease, ulcerative colitis, lupus erythematosis, psoriasis |
| 01/14/2010 | US20100010037 1h-pyrrolo[2,3-b]pyridine derivatives useful as hsp90 inhibitors |
| 01/14/2010 | US20100010033 Bis-carbazole DNA intercalating agents for antitumor therapy |
| 01/14/2010 | US20100010032 Camptothecin derivatives with antitumor activity |
| 01/14/2010 | US20100010023 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/14/2010 | US20100010022 Use of pazopanib HCl and lapatinib |
| 01/14/2010 | US20100010016 Bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | US20100010014 Aminopyrimidine compounds and methods of use |
| 01/14/2010 | US20100010010 Hdac inhibitors |
| 01/14/2010 | US20100010008 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100010002 Anticancer use of caffeic acid and its derivatives |
| 01/14/2010 | US20100009998 Compositions and Methods Employing Aminopterin |
| 01/14/2010 | US20100009992 Ampk modulators |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009982 Modulators of Acetyl-Coenzyme A Carboxylase and Methods of Use Thereof |
| 01/14/2010 | US20100009978 Benzoxazoles and Oxazolopyridines Being Useful as Janus Kinases Inhibitors |
| 01/14/2010 | US20100009963 Kinase antagonists |
| 01/14/2010 | US20100009958 Quinazoline derivatives |
| 01/14/2010 | US20100009949 Novel method |
| 01/14/2010 | US20100009945 3,2-dihydrofuran-1 alpha ,25-dihydroxy-19-nor-vitamin D3; prophylaxis of autoimmune diseases, some types of cancers, metabolic bone diseases, osteomalacia, osteopenia, secondary hyperparathyroidism, psoriasis, or other skin diseases; osteoporosis |
| 01/14/2010 | US20100009944 19-Nor-Vitamin D Analogs with 1,2-Dihydrofuran Ring |
| 01/14/2010 | US20100009943 2-Methylene-(22E)-25-(1-Methylene-Hexyl)-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009940 2-Methylene-(20E)-20(22)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009929 Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof |
| 01/14/2010 | US20100009928 Compositions including triciribine and taxanes and methods of use thereof |
| 01/14/2010 | US20100009926 Ph-sensitive polymeric micelles for drug delivery |
| 01/14/2010 | US20100009920 Ttk as tumor marker and therapeutic target for lung cancer |
| 01/14/2010 | US20100009918 Method for the administration of ligands, agonists of ligands of the tnf family with reduced toxicity |
| 01/14/2010 | US20100009915 Compositions comprising fungal immunomodulatory protein and use thereof |
| 01/14/2010 | US20100009909 Peptides binding the phosphatase 2a protein |
| 01/14/2010 | US20100009906 Anticancer Treatments |
| 01/14/2010 | US20100009895 Method for selective localization of active agents at and in mitochondria and corresponding active agents |
| 01/14/2010 | US20100009439 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAs, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS |
| 01/14/2010 | US20100009435 SPECIFIC GRP78 EXPRESSION-INHIBITION RNAi SEQUENCE, MEDICINE THEREOF AND METHOD THEREOF |
| 01/14/2010 | US20100009019 Processes for Extracting Phytochemicals from Pomegranate Solids and Compositions and Methods of Use Thereof |
| 01/14/2010 | US20100009017 Anticancer Methods Using Extracts of Anemarrhena asphodeloides Bunge |
| 01/14/2010 | US20100009000 Granule and preparation method thereof |
| 01/14/2010 | US20100008998 Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof |
| 01/14/2010 | US20100008982 Non-covalent complexes of bioactive agents with starch for oral delivery |
| 01/14/2010 | US20100008978 Nanoparticles effective for internalization into cells |
| 01/14/2010 | US20100008975 Predicting response to a HER inhibitor |
| 01/14/2010 | US20100008971 Chewing composition comprising coenzyme q10 |
| 01/14/2010 | US20100008966 Medical Devices and Methods for Delivery of Nucleic Acids |
| 01/14/2010 | US20100008964 Isolated stromal cells and methods of using the same |
| 01/14/2010 | US20100008953 Process for producing poxviruses and poxvirus compositions |
| 01/14/2010 | US20100008946 Microorganisms for therapy |
| 01/14/2010 | US20100008935 Method for identifying therapeutical targets in tumors, the use thereof and means for determining and targeting angiogenesis and hemostasis related to andenocarcinomas of the lung |
| 01/14/2010 | US20100008931 Coronin 1 Modulators for the Treatment of Autoimmune and Lymphoproliferative Disorders and Mycobacterial Infections |
| 01/14/2010 | US20100008929 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 01/14/2010 | US20100008926 Novel proteins and use thereof |
| 01/14/2010 | US20100008923 Organic Compounds |
| 01/14/2010 | US20100008919 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; Using copper binding protein as a delivery vehicle; used to inhibit angiogenesis that accompanies tumor development |
| 01/14/2010 | US20100008906 Cripto binding molecules |